UnknownNot Applicable

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

United States50 participantsStarted 2022-04-01

Plain-language summary

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject must be 18 years or older at the time of screening
✓. Males, Females, Transgender Male and Transgender Females
✓. HIV positive
✓. Positive antibody to HSV- 1/and or HSV-2
✓. If Female of child baring potential, documented negative pregnancy test at the time of screening.

Exclusion criteria

✕. Active opportunistic infection
✕. Current chemotherapy
✕. Unable to give informed consent

What they're measuring

Epidemiology

Timeframe: 48 weeks

Trial details

NCT IDNCT05823779

SponsorGlobal Research Institute

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-12-31

Contact for this trial

Jorge E Rodriguez, M.D.

(323) 934-3690 2jrodmd@gmail.com

View on ClinicalTrials.gov More HIV Disease trials